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Patients Characteristics
Case Diagnosis CD3/kg CD34/kg Chimeras Acute GVHD Status/time post-transplant
1 ALL in 3 CR 2x106 18x106 86% No Alive-Remission/ 9 months
2 ALL in 3 CR 5x105 10x106 100% No Alive-Remission/ 2 months
3 ALL in 2 CR 2x105 12x106 13% No Alive-Remission/ 2 months
4 AML in 2 CR 6x105 6.9x106 100% Skin grade III Relapse at 3 months/
5 Sickle cell disease 14x105 7.8x106 Pending No Alive/1 month
6 Sickle cell disease/ Thalasemia 13x105 8.6x106 86% No Alive/ 2 month
7 ALL high risk in 1 CR 3.4x105 12x106 100% Skin grade I Alive-Remission/ 4 months
8 ALL in 2 CR 8.6x105 6.7x106 90% Skin and intestine II Alive-Remission/ 4 months.
9 AML in 2 CR 2.1x106 11.2x106 — — —
10 ALL in 2 CR 1.2 x106 15 x106 — — —
S296 Poster Session IIexist or will not be found within an acceptable time frame for a sub-
stantial portion of the remaining patients. Haploidentical HCT is
a viable alternative since almost every patient has at least a haplo-
type-sharing parent, child, or sibling available to donate stem cells,
but it has been limited by high risk of severe graft-versus-host disease
(GVHD), graft rejection, life-threatening infections, and relapse—
all of which are partially caused by intensive immunosuppressive
therapy and T-cell depletion.
Patients and methods: Between January and October 2009 all
pediatric patients (ten patients) in our center who needed trans-
plant without a suitable donor were included in our haploident-
ical transplant program. The median age of the patients was 7
years (range between 2 and 11 years), five boys and five girls.
The HLA compatibility was 7/10 in one patient, 8/10 in one pa-
tient and 5/10 in 8 patients. In all the cases the mother was the
donor.
The patients received the following conditioning regimen in out-
patient basis, thymoglobulin (from day -10 to day -7), cyclophospha-
mide (from day -6 to day -3), fludarabine (from day -6 to day -3), (on
day -2), cyclosporine (begin day -1), stem cells infusion (day 0).
GVHD was with prednisone, cyclosporine and low doses of metho-
trexate, and, depending on the T cell dose, mycophenolate was used.
More characteristics are show in table 1.
Results: Eight of 10 patients could be evaluated. Engraftment was
achieved in all patients. However, two of them rejected afterwards.
One patient received a second cells infusion. Three patients pre-
sented mild GVHD. A bone marrow relapse happened in a patient
with acute myelogenous leukemia, and a patient die for transplant
lymphoproliferative disorder without neoplastic activity and with
a 100% chimerism.
Conclusions: We have demonstrated in a small group of patients
that the use of stem cells from haploidentical parental donors should
be strongly considered in children who need transplantation but lack
of a match-related donor. Long-term follow-up and a large number
of patients for a better analysis are needed.376
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Background: Intestinal perforation in the setting of post-transplant
microangiopathy (TMA) is a very rare event and might be considered
a terminal event of intestinal microangiopathy (i-TMA), a rather
rarely recognized post-transplant complication, as it overlaps with
the more common intestinal graft-versus-host-disease (GVHD).
Cases of i-TMA described in literature occurred within with first
100-days post-transplant or shortly thereafter. The aim of this study
is to describe two cases of late onset intestinal perforation thatoccurred in the setting of systemic microangiopathy more than
a year post allogeneic transplant.
Results: One patient presented 380 days post matched unrelated
allogeneic transplantation with acute respiratory distress second-
ary to diffuse alveolar hemorrhage. Five days later she developed
constipation and abdominal distension. An ultrasound of the ab-
domen revealed portal venous gas and multiple loops of dilated
fluid filled bowel concerning for bowel ischemia. She underwent
exploratory laparatomy and subsequent subtotal colectomy. Path-
ologic examination confirmed ischemic necrosis. She fulfilled the
criteria for TMA diagnosis and was started on plasmapheresis
and rituximab. Tacrolimus was discontinued prior to her admis-
sion. Despite these measures, the patient passed away from pro-
gressive TMA 17 days after surgery. The second patient
presented two years post matched unrelated donor transplant
with abdominal pain in the setting of sepsis. Admission CT
scan revealed perisplenic gas and fluid collection concerning for
possible abscess. An exploratory laparatomy revealed diffuse is-
chemic large bowel requiring a hemicolectomy. Pathologic exam-
ination was consistent with chronic ischemic changes with
intestinal mucosal fibrosis and focal ulceration. He also fulfilled
the criteria for diagnosis of TMA and calcineurin inhibitor was
discontinued. Ultimately, he died of sepsis and unresponsive
TMA. Both patients, prior to their presentation, were treated
for chronic GVHD of the liver and lower gastrointestinal tract
with steroids in addition to tacrolimus. The final pathologic
exam did not show evidence of GVHD in the first case, but
did show crypt apoptosis and crypt abscess in the second case,
raising the possibility of associated GVHD.
Conclusion: Intestinal perforation in the setting of TMA can oc-
cur as a late post-transplant complication, and is associated with
poor response to treatment secondary to refractory mircoangio-
pathy.377
RESPONSES TO A QUESTIONNAIRE FOR PATIENTS ABOUT BONE MAR-
ROW TRANSPLANTATION
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Introduction: In the context of our focus on treatment by hemato-
poietic cell transplantation as part of therapy a questionnaire was de-
veloped to offer patients visiting the website or link at a public sites to
respond.
Method:A survey was prepared containing 20 questions, 6 related to
general responders characteristics, 10 to autologous and allogeneic
transplantation, and 4 to donation of bone marrow, interest in edu-
cation about transplantation and donation for clinical research or
treatment by transpant. All yes/no questions also had the option
not applicable or uncertain.
The results were analysed as % of all responders and % of re-
sponders to a question. Herein we present as % of all respondsers.
